| Literature DB >> 20219542 |
Jaqueline Gontijo de Souza1, Flávio Guimarães da Fonseca, Olindo Assis Martins-Filho, Andrea Teixeira-Carvalho, Camila Pacheco Silveira Martins, Luciana Debortoli Carvalho, Jordana Grazziela Alves Coelho-Dos-Reis, Edel Figueiredo Barbosa-Stancioli.
Abstract
Human T-lymphotropic virus 1 (HTLV-1) induces an immune-mediated inflammatory disease affecting the nervous system that eventually is accompanied by ocular, rheumatic and dermatologic manifestations (HTLV-1 associated myelopathy/tropical spastic paraparesis, or HAM/TSP). Proviral load and HTLV-1 protein expression, mainly of Tax, is correlated with disease progression and induction of host-virus equilibrium breakdown that, reportedly, involves the presence of Tax-specific cytotoxic T lymphocytes (CTL), T regulatory cells and anti-Tax antibodies. Based on knowledge of anti-Tax antibodies as markers of disease progression, the objectives of this study were both to design an infection/transfection system using the Vaccinia virus and a tax-encoding plasmid for the expression of Tax protein as well as to use this cell support to evaluate anti-Tax IgG by flow cytometry. The flow cytometry assay was standardized using pooled sera from each test group (negative, asymptomatic and HAM/TSP patients). The HAM/TSP group presented higher IgG anti-Tax reactivity (above 70%) than the asymptomatic group (nearly 40% reactivity). The data indicate that the infection/transfection system is useful for assessing Tax expression. This is a promising assay for use as a diagnostic tool to detect IgG anti-Tax and monitor HTLV-1 infected individuals. Copyright 2010 Elsevier B.V. All rights reserved.Entities:
Mesh:
Substances:
Year: 2010 PMID: 20219542 DOI: 10.1016/j.jviromet.2010.02.021
Source DB: PubMed Journal: J Virol Methods ISSN: 0166-0934 Impact factor: 2.014